Latest news with #Idrees
Atlantic
7 days ago
- Business
- Atlantic
The Atlantic Hires Idrees Kahloon as Staff Writer
As The Atlantic continues to expand its editorial team, today it announced the hire of Idrees Kahloon as a staff writer. Idrees is currently the Washington bureau chief of The Economist. This week, The Atlanti c also announced two additional staff writers: Vivian Salama, joining next month from The Wall Street Journal to cover national security and foreign policy; and Tom Bartlett, who began yesterday to cover health and science under the second Trump administration. Tom was a staff writer for 22 years at The Chronicle of Higher Education. Below is the staff note about Idrees from editor in chief Jeffrey Goldberg, executive editor Adrienne LaFrance, deputy executive editor Yoni Appelbaum, and deputy editor Juliet Lapidos: Dear All, For the next installment in our continuing series Someone Amazing Is Joining The Atlantic, we are pleased to announce that Idrees Kahloon is Joining The Atlantic. Idrees is currently the Washington bureau chief of The Economist, where he leads coverage of national politics. Although The Economist treats authorship like a state secret, we have ascertained that Idrees was behind some of that magazine's best, most compelling stories, including, What If Joe Biden Decided Against Running for Re-Election?, published in 2023. (Idrees pointed out in this piece that the Democratic bench has plenty of talent.) He also wrote a special report on the geography of poverty and opportunity in America. Idrees started at The Economist right out of college, as a data journalist. While still in school he interned with the editorial boards of The Lexington Herald-Leader and The Pittsburgh Post-Gazette. And he has moonlighted as a critic for The New Yorker, writing Books essays on Thomas Piketty and Richard Reeves, among others. Idrees likes to cook in his spare time––though he doesn't have much of that, since he recently became a father––and claims he enjoys reading the novels of Thomas Hardy. Please join us in welcoming him to the team. Best wishes, Jeff, Adrienne, Yoni and Juliet The Atlantic has welcomed a number of editors and writers this year, including managing editor Griff Witte; staff writers Isaac Stanley-Becker, Tyler Austin Harper, Quinta Jurecic, Nick Miroff, Toulouse Olorunnipa, Ashley Parker, Alexandra Petri, Missy Ryan, Michael Scherer, Jamie Thompson, Josh Tyrangiel, Caity Weaver, and Nancy Youssef; and senior editors Jenna Johnson and Dan Zak. Please reach out with any questions or requests.
BBC News
10-07-2025
- Health
- BBC News
Oxford family want more funding for research into rare diseases
Six-year-old Idrees plays happily in the garden of his Oxford home, with his older sister Eliza. He can keep up with her now, but a year ago he was struggling with symptoms caused by a very rare metabolic disease, Niemann-Pick."His liver and spleen were enlarged and it affected his lung capacity, so he would get breathless," said dad Qasim. "He was in a pram until last year." "When doctors said his life expectancy would be very short, we were devastated. Our world came tumbling down." Shortly after Idrees's diagnosis in April last year, a potential treatment emerged, but it was rejected by the National Institute for Health and Care Excellence (NICE). "Knowing your grandson has a devastating disease is only made worse by knowing there is a treatment which he can't access," said Nasreen, Idrees' the drug company is offering Idrees treatment under special "compassionate use grounds" but that is not guaranteed to continue. "It's absolutely changed his life and ours. He's not being teased at school. He could only do 10% of what his sister could at his age. But now he's caught up." said his dad. Niemann-Pick is a rare disease, affecting only about 40 people in the UK. There is no about 3.5 million people in the UK have other rare diseases and for 95% of the 6,000 known rare conditions there is no approved treatment - while about one in three people wait more than five years for a diagnosis. The life sciences not-for-profit organisations LifeArc and Genetic Alliance UK say that needs to change. They are calling for the government, NHS, researchers, industry, patient groups and policymakers to work together to transform a new report, they make several recommendations to "streamline research and development, create an attractive environment for investment and drive progress for people with rare diseases"."The challenges we face are clear – but so is the potential for meaningful change," said Dr Sam Barrell, chief executive officer of LifeArc."We must act today to demand better, to work together and to transform the system for the millions of people living with rare diseases." 'Better future' The report comes at a pivotal time, as the government is considering the future of the Rare Disease Framework, which sets out a national vision for how the UK will improve the lives of those living with rare diseases.A Department of Health and Social Care spokesperson said "We know that those living with rare diseases and their families face immense everyday challenges."One of the top priorities will be to improve access to specialist care, treatment, and drugs for patients."Our 10-year Health Plan will also help turn cutting-edge research into treatments for people with rare diseases, such as advancing genomic testing to accelerate diagnoses."Qasim hopes that will help Idrees and others like him. "We need to be the leaders in finding solutions. I want everyone to work together to secure a better future for the children of this country." You can follow BBC Oxfordshire on Facebook, X, or Instagram.
